NCT03789773

Holographic Mm-Wave Imaging in Patients Undergoing Radiation Therapy

Holographic Mm-wave Imaging in Radiation Oncology

• Status: Withdrawn
• Phase: N/A
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: University of Southern California · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

This trial studies the quality of holographic mm-wave imaging in patients undergoing radiation therapy. Holographic mm-wave imaging is a common type of imaging used in airport body scanners that may be helpful in improving the efficiency and positioning of radiation oncology patients and their overall experience.

Detailed description

PRIMARY OBJECTIVES: I. To obtain patient images in a clinical setting and assess their quality. SECONDARY OBJECTIVES: I. To assess the registration agreement through a voxel-voxel distance-to-agreement metric. OUTLINE: Patients undergo holographic mm-wave imaging in radiotherapy treatment position after initial computed tomography (CT) simulation.

Conditions

• Unspecified Adult Solid Tumor

Interventions

Type	Name	Description
DEVICE	Millimeter-Wave Holographic Imaging	Undergo mm-wave holographic imaging

Timeline

• Start date: 2022-12-01
• Primary completion: 2023-12-01
• Completion: 2024-12-01
• First posted: 2018-12-31
• Last updated: 2023-02-01

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study